Correlation Between Pasithea Therapeutics and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Entero Therapeutics,, you can compare the effects of market volatilities on Pasithea Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Entero Therapeutics,.
Diversification Opportunities for Pasithea Therapeutics and Entero Therapeutics,
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Pasithea and Entero is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Entero Therapeutics,
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Entero Therapeutics,. In addition to that, Pasithea Therapeutics is 2.02 times more volatile than Entero Therapeutics,. It trades about -0.2 of its total potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.03 per unit of volatility. If you would invest 54.00 in Entero Therapeutics, on November 18, 2024 and sell it today you would lose (3.00) from holding Entero Therapeutics, or give up 5.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Entero Therapeutics,
Performance |
| Timeline |
| Pasithea Therapeutics |
| Entero Therapeutics, |
Pasithea Therapeutics and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Entero Therapeutics,
The main advantage of trading using opposite Pasithea Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
| Entero Therapeutics, vs. Crinetics Pharmaceuticals | Entero Therapeutics, vs. Rhythm Pharmaceuticals | Entero Therapeutics, vs. Kura Oncology | Entero Therapeutics, vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |